Published by Alexander Bueso on 22nd January 2021
(Sharecast News) - An antibody therapy developed by Eli Lilly reduced the risk of Covid-19 symptoms among residents of nursing homes by as much as four-fifths, a study showed.
URL: http://www.digitallook.com/dl/news/story/31594296/...